Background: The significant role of red blood cell distribution width (RDW) and D‐Dimer as prognostic factors in patients with some blood malignancies has been reported recently.Aim: We designed and performed a meta‐analysis to investigate the prognostic roles of RDW and D‐Dimer in subjects with diffuse large B‐cell lymphoma (DLBCL).Materials and Methods: We systematically reviewed PubMed‐Medline, SCOPUS, EMBASE, Web of Science Core Collection, and Google Scholar up to the present to look for publications on prognostic effects of RDW and D‐Dimer in DLBCL patients. For investigation of the associations between RDW and D‐Dimer with the overall survival (OS) and progression‐free survival (PFS) of the DLBCL cases, hazard ratio (HR) with 95% confidence intervals (CIs) was used.Results: We included 13 eligible studies in the present meta‐analysis. The results of pooled analysis showed that increased levels of RDW was related to poor OS (HR = 2.01, 95% CI: 1.62–2.48, p value <.01, I2 = 0%) and poor PFS (HR = 1.52, 95% CI: 1.24–1.85, p value <.01, I2 = 16%) among the DLBCL patients. Similarly, a significant relationship was found between increased D‐Dimer and poor OS (HR = 2.30, 95% CI: 1.03–5.14, p value <.05, I2 = 95%) of the DLBCL patients as well. In addition, there was no significant heterogeneity in OS (p value H = 0.65) and PFS (p value H = 0.31) related to RDW among studies included in the meta‐analysis.Conclusion: Our finding clearly confirmed that elevated RDW levels and D‐Dimer were associated with adverse OS and PFS in DLBCL.
Background: Evidence indicates that beta‐2 microglobulin (β2M) plays a prognostic role in patients with diffuse large B‐cell lymphoma (DLBCL). Aim: However, due to controversies among previous studies, this meta‐analysis was conducted to evaluate the prognostic role of β2M in DLBCL patients. Methods and Results: Relevant studies were identified through a systematic search using specific keywords in PubMed/Medline, Scopus, and Web of Science databases. Studies that provided complete information on the hazard ratio with a 95% confidence interval for β2M with respect to overall survival (OS) and progression‐free survival (PFS) in multivariate models were included in the meta‐analysis. A total of 30 studies, encompassing 25 128 patients, were included in this meta‐analysis. The pooled analysis demonstrated a significant association between elevated β2M levels and poor OS in DLBCL patients (HR Pooled : 1.65, 95% CI: 1.45–1.88, p ‐value < 0.01). Similarly, increased β2M levels were significantly associated with lower PFS in DLBCL patients (HR Pooled : 1.54, 95% CI: 1.39–1.70, p ‐value < 0.01). Conclusion: The available evidence suggests that β2M serves as an independent prognostic marker with significant effects on OS and PFS in DLBCL patients. Elevated serum β2M levels are associated with poor prognosis and worse OS and PFS outcomes in DLBCL patients.
1 January 2024 in Translational and Clinical Pharmacology
Introduction: Non-fatal injuries resulting from road accidents present a significant public health challenge, with profound physical, psychological, and economic consequences for individuals. Given the importance of emotional regulation in post-accident recovery, examining this aspect among accident victims is essential. This study aimed to investigate and compare cognitive emotion regulation strategies between ...
Introduction: Trauma is one of the most critical health problems worldwide. In the trauma of the elderly, the rate of complications and mortality is high. This study aimed to investigate the relationship between Base Deficit (BD) and morbidity and mortality in elderly trauma patients. Methods: This cross-sectional study was performed ...
5 August 2024 in Journal of Diabetes & Metabolic Disorders